Newly diagnosed patients with KRAS G12C-mutant advanced or metastatic nonsquamous NSCLC will be enrolled in the trial.

Rio Tinto and Glencore previously held deal talks in late 2024, but they ended over issues including valuation, the chief ...

An Auckland woman who is self-funding treatment for her rare, aggressive breast cancer is fed up after years of asking the ...

Merck stock earns a cautious "Buy." Learn more about its valuation, Keytruda risks, pipeline potential, and long-term growth.

At the JPMorgan Healthcare Conference, drugmakers are expected to roll out key business and drug pipeline updates and splashy ...

Dow Jones Industrial Average, Chevron Corp, Coca-Cola Co, Merck & Company Inc. Read 's Market Analysis on Investing.com ...

Pfizer ( PFE +0.24%) pays a dividend that yields around 6.8%. While the yield has been pushed higher as share prices have ...

Countries like Spain have used 'most-favored-nation' drug pricing for decades. While it may reduce the cost of drugs, it will ...

SmartMoving, the profitability platform built for modern moving companies, today announced its acquisition of Remedy Payments, the most trusted name in embedded payment solutions for the moving and ...

Quick Fix Synthetic, the official distributor of Spectrum Labs' Quick Fix products, today issued guidance for laboratory professionals regarding temperature-related specimen failures. Federal ...

CT scan of chest, abdomen, and pelvis shows high-disease burden, including multiple mediastinal and hilar nodes, deposits in ...

Reviva Pharmaceuticals Holdings Inc. may be headed back to the clinic for another phase III study of brilaroxazine in treating schizophrenia. The U.S. FDA recommended the second study for the ...